Shimon Rapps
Director/Board Member bij GLUCOTRACK, INC.
Vermogen: 3 508 $ op 31-03-2024
Profiel
Shimon Rapps is an Independent Director at GlucoTrack, Inc. since 2019.
He previously worked as the Head of Investment Banking at Andrew Garrett, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GLUCOTRACK INC
0.04% | 17-02-2023 | 10 598 ( 0.04% ) | 3 508 $ | 31-03-2024 |
Actieve functies van Shimon Rapps
Bedrijven | Functie | Begin |
---|---|---|
GLUCOTRACK, INC. | Director/Board Member | 30-07-2019 |
Eerdere bekende functies van Shimon Rapps
Bedrijven | Functie | Einde |
---|---|---|
Andrew Garrett, Inc.
Andrew Garrett, Inc. Investment Banks/BrokersFinance Andrew Garrett, Inc. is an independent, registered broker-dealer firm which was founded by Drew G. Sycoff in 1992. Headquartered in New York City, the firm provides market expertise, advice, execution, distribution and customized products to a wide network of institutional and private clientele worldwide including insurance companies, asset managers, hedge funds, pension funds, and mutual funds. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GLUCOTRACK, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Andrew Garrett, Inc.
Andrew Garrett, Inc. Investment Banks/BrokersFinance Andrew Garrett, Inc. is an independent, registered broker-dealer firm which was founded by Drew G. Sycoff in 1992. Headquartered in New York City, the firm provides market expertise, advice, execution, distribution and customized products to a wide network of institutional and private clientele worldwide including insurance companies, asset managers, hedge funds, pension funds, and mutual funds. | Finance |